About US
Contact us
-
Ex-Genentech staffers plead guilty to trade secrets theft as DOJ targets biotech partners for $101M Sanofi dealA lawsuit that charges ex-staffers at Roche’s Genentech withtrade secrets theft nears closure as key insiders plead guilty. But federal prosecutors are now targeting their co-conspiratorswho allegedl2021/7/9
-
Is China's drug regulator suddenly raising the bar on cancer med R&D? Not exactly, say expertsChina’s drug regulators released a draft guideline on cancer therapy development last week. Stock prices of several leading oncology drugmakers and CROs took a beating as investors feared the new rul2021/7/9
-
GlaxoSmithKline touts 'widespread' investor support, backs CEO Walmsley in heated fight with ElliottA proxy fight is gaining steam at GlaxoSmithKline. Buoyed by “widespread and strong” investor support, the company is hitting back at Elliott Management, which just yesterday attacked the leadership2021/7/6
-
U.K. Supreme Court rejects NHS claim of €220M financial loss in Servier patent lawsuitIn the culmination of a 10-year case, the U.K. Supreme Court hasruledin favor of Servier Laboratories in its defense against England’s National Health Service over a patent on cardio drug Coversyl.2021/7/6
-
Bayer's gene therapy CDMO Viralgen cuts ribbon on first phase of $142M viral vector expansionViralgen, the gene therapy CDMO coinedby Bayer’s Asklepios BioPharmaceutical, is wading into commercial waters. The Spanish contractor on Wednesdaysaiditcut the ribbon on the first $83 million piece2021/7/1
-
Eyeing $600M in peak sales, Scynexis preps ambitious launch for antifungal BrexafemmeEyeing the outskirts of blockbuster land with its newly minted antifungal, Jersey City's Scynexis is hitting the gas with a drug launch into a massive and largely deserted field. The new drug, Brexaf2021/7/1
-
WuXi's STA to build massive manufacturing facility in Delaware, adding 500 jobs“Project Dragonfly,” STA Pharmaceutical’s codenamed plan to build a massive manufacturing facility, has emerged from the cover of darkness, brought into the light by a $19 million grant from the stat2021/6/30
-
Amgen pumps $365M into new Ohio 'smart facility,' where 400 staffers will be aided by robots, AI and moreOhio hasrecently proved an alluring target for biopharmas of all sizes, from gene therapy player Sarepta Therapeutics tobiotech-CDMO hybrid Forge Biologics. Now, Big Pharma Amgen is getting in on the2021/6/30
-
In collab with Novo Nordisk, Walmart says it will 'revolutionize' insulin access with deep discountsInsulin costs have been a controversial topic in pharmafor years, with the leading manufacturers facing routine scrutiny for their pricing strategies. In a move poised to shake up themarket, Walmart2021/6/28
-
Novartis, GBT sickle cell drugs face coverage hurdles as gene therapy threats loom: surveyNovartis’ Adakveo and Global Blood Therapeutics’ Oxbryta started their commercial life in 2019 as novel drugs for sickle cell disease. While physicians like their efficacy and safety profiles, formul2021/6/28